{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:51:49Z","timestamp":1781650309242,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021546","name":"Suez University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021546","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The transition from chronic liver disease to cirrhosis and ultimately hepatocellular carcinoma (HCC) is accompanied by progressive systemic alterations involving hematologic, metabolic, and inflammatory pathways. Understanding these interconnected changes may refine disease characterization and support early diagnostic or prognostic stratification, especially in high-burden regions such as Egypt. This study aimed to delineate the comprehensive clinical, hematologic, metabolic, and inflammatory profiles distinguishing Egyptian patients with HCC and liver cirrhosis from healthy controls, and to evaluate the diagnostic and discriminative utility of novel systemic inflammatory indices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this comparative cross-sectional study, 211 participants were enrolled: 70 with HCC, 71 with HCV-related cirrhosis, and 70 healthy controls. Clinical, biochemical, and hematologic parameters were measured, including liver and renal function, lipid profile, and alpha-fetoprotein (AFP). Composite inflammatory indices were calculated: Systemic Inflammation Response Index (SIRI\u2009=\u2009neutrophils \u00d7 monocytes\/lymphocytes) and GGT-to-Lymphocyte Ratio (GLR\u2009=\u2009GGT \/ lymphocytes). Group comparisons were performed using non-parametric tests. Correlations between indices and clinical or tumor features were analyzed by Spearman\u2019s coefficient. Diagnostic performance was assessed using ROC curve analysis and multivariable logistic regression adjusted for age and sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Both patient groups demonstrated marked systemic dysregulation relative to controls. Hemoglobin, platelet count, albumin, and HDL-C were significantly reduced, whereas bilirubin, transaminases, ALP, INR, AFP, and insulin were progressively elevated (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Gamma-glutamyl transferase (GGT) was significantly elevated in both patient groups compared to controls, with the highest levels observed in the HCC group. The inflammatory indices SIRI and GLR were significantly higher in cirrhosis and HCC (median SIRI: 1.25 vs. 1.2 vs. 0.6;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). GLR, in particular, demonstrated strong discriminatory performance for distinguishing HCC from cirrhosis (AUC\u2009=\u20090.881; 95% CI 0.842\u20130.921;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), achieving significantly higher diagnostic accuracy than SIRI (AUC\u2009=\u20090.742). Subgroup analysis confirmed its superior diagnostic accuracy, especially in patients with advanced liver dysfunction (Child-Pugh B\/C; AUC\u2009=\u20090.92). Furthermore, a high GLR (&gt;\u200922.5) was an independent predictor of reduced overall survival in the HCC cohort (adjusted HR\u2009=\u20092.95;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004). In multivariable models, elevated GLR and low albumin independently predicted HCC presence (adjusted ORs 2.31 and 0.54, respectively;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Distinct and progressively severe hematologic, metabolic, and inflammatory disturbances characterize the continuum from cirrhosis to HCC. The Gamma-Glutamyl Transferase-to-Lymphocyte Ratio (GLR) showed a strong association with the presence of HCC and demonstrated strong discriminatory performance (AUC\u2009=\u20090.881) for its differentiation from cirrhosis, suggesting it is a promising candidate worthy of further validation in surveillance programs for high-risk Egyptian patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-026-04752-2","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:41:30Z","timestamp":1776058890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic hematologic, metabolic, and inflammatory dysregulation in liver cirrhosis and hepatocellular carcinoma: diagnostic utility of novel indices in an Egyptian cohort"],"prefix":"10.1186","volume":"26","author":[{"given":"Dalia E.","family":"Sherief","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeer Hamdy","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"Nosair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8191-0035","authenticated-orcid":false,"given":"Amira A. A.","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed W.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Sadaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Elgamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"3","key":"4752_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"10127","key":"4752_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M. Carcinoma Bruix JHepatocellular. Lancet. 2018;391(10127):1301\u20134.","journal-title":"Lancet"},{"key":"4752_CR3","unstructured":"El-Zanaty F, Way A. Egypt Demographic and Health Survey 2014: Ministry of Health. El-Zanaty and Associates, Cairo, Egypt, and Macro International, and Rockville, MD. 2015."},{"issue":"1","key":"4752_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/liv.13186","volume":"37","author":"A Kandeel","year":"2017","unstructured":"Kandeel A, Genedy M, El-Refai S, Funk AL, Fontanet A, Talaat M. The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment. Liver Int. 2017;37(1):45\u201353.","journal-title":"Liver Int"},{"issue":"8","key":"4752_CR5","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1053\/j.gastro.2016.01.025","volume":"150","author":"B Gao","year":"2016","unstructured":"Gao B, Tsukamoto H. Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe? Gastroenterology. 2016;150(8):1704\u20139.","journal-title":"Gastroenterology"},{"issue":"9","key":"4752_CR6","doi-asserted-by":"publisher","first-page":"e2335511","DOI":"10.1001\/jamanetworkopen.2023.35511","volume":"6","author":"C Liu","year":"2023","unstructured":"Liu C, Liu T, Zhang Q, Jia P, Song M, Zhang Q, Ruan G, Ge Y, Lin S, Wang Z, Xie H. New-onset age of nonalcoholic fatty liver disease and cancer risk. JAMA Netw Open. 2023;6(9):e2335511.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4752_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3350\/cmh.2020.0302","volume":"27","author":"N Nishida","year":"2020","unstructured":"Nishida N. Metabolic disease as a risk of hepatocellular carcinoma. Clin Mol Hepatol. 2020;27(1):87.","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"4752_CR8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","volume":"19","author":"M Ringelhan","year":"2018","unstructured":"Ringelhan M, Pfister D, O\u2019Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19(3):222\u201332.","journal-title":"Nat Immunol"},{"issue":"8","key":"4752_CR9","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1080\/00365521.2020.1788139","volume":"55","author":"KM Kim","year":"2020","unstructured":"Kim KM, Shim SG, Sinn DH, Song JE, Kim BS, Kim HG, Child-Pugh MELD. MELD-Na, and ALBI scores: which liver function models best predicts prognosis for HCC patient with ascites? Scand J Gastroenterol. 2020;55(8):951\u20137.","journal-title":"Scand J Gastroenterol"},{"key":"4752_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2017.06.002","volume":"116","author":"RD Dolan","year":"2017","unstructured":"Dolan RD, McSorley ST, Horgan PG, Laird B, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis. Crit Rev Oncol\/Hematol. 2017;116:134\u201346.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"14","key":"4752_CR11","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/cncr.30057","volume":"122","author":"Q Qi","year":"2016","unstructured":"Qi Q, Zhuang L, Shen Y, Geng Y, Yu S, Chen H, Liu L, Meng Z, Wang P, Chen Z. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016;122(14):2158\u201367.","journal-title":"Cancer"},{"issue":"50","key":"4752_CR12","doi-asserted-by":"publisher","first-page":"e23486","DOI":"10.1097\/MD.0000000000023486","volume":"99","author":"L Wei","year":"2020","unstructured":"Wei L, Xie H, Yan P. Prognostic value of the systemic inflammation response index in human malignancy: a meta-analysis. Medicine. 2020;99(50):e23486.","journal-title":"Medicine"},{"issue":"1","key":"4752_CR13","first-page":"3533714","volume":"2022","author":"X Peng","year":"2022","unstructured":"Peng X, Huang Y, Zhang M, Chen Y, Zhang L, He A, Luo R. Prognostic and Clinical Significance of Aspartate Aminotransferase-to\u2010Lymphocyte Ratio Index in Individuals with Liver Cancer: A Meta\u2010Analysis. Dis Markers. 2022;2022(1):3533714.","journal-title":"Dis Markers"},{"issue":"2","key":"4752_CR14","doi-asserted-by":"publisher","first-page":"98578","DOI":"10.4240\/wjgs.v17.i2.98578","volume":"17","author":"PC Zhou","year":"2025","unstructured":"Zhou PC, Huang R, Wang HT, Yang J, Peng JD, Fu ZX, Liao WJ, Ma HQ, Wu LQ, Li EL. Gamma-glutamyl transferase-to-lymphocyte ratio as a prognostic marker in patients with hepatocellular carcinoma undergoing hepatectomy. World J Gastrointest Surg. 2025;17(2):98578.","journal-title":"World J Gastrointest Surg"},{"issue":"1","key":"4752_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s43162-023-00201-8","volume":"35","author":"AA Ali","year":"2023","unstructured":"Ali AA, Gamal SE, Anwar R, Elzahaf E, Eskandere D. Assessment of clinico-epidemiological profile of Hepatocellular carcinoma in the last two decades. Egypt J Intern Med. 2023;35(1):18.","journal-title":"Egypt J Intern Med"},{"issue":"20","key":"4752_CR16","doi-asserted-by":"publisher","first-page":"15451","DOI":"10.3390\/ijms242015451","volume":"24","author":"B Rankovi\u0107","year":"2023","unstructured":"Rankovi\u0107 B, Hauptman N. Circulating microRNA panels for detection of liver cancers and liver-metastasizing primary cancers. Int J Mol Sci. 2023;24(20):15451.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4752_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 P ractice G uidance by the A merican A ssociation for the Study of Liver Diseases. Hepatology. 2018;68(2):723\u201350.","journal-title":"Hepatology"},{"issue":"5","key":"4752_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21608\/mjcc.2025.426657.1033","volume":"68","author":"AA Abdelfatah","year":"2025","unstructured":"Abdelfatah AA, Youssef MM, Abdel-Wahab M, Gouida MS, El-Emshaty HM. Predictive Significance of the Inflammatory Activities and GGT in Hepatocellular Carcinoma Development. Mansoura J Chem. 2025;68(5):1\u20139.","journal-title":"Mansoura J Chem"},{"issue":"8","key":"4752_CR19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646\u20139.","journal-title":"Br J Surg"},{"issue":"1","key":"4752_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32\u20135.","journal-title":"Cancer"},{"key":"4752_CR21","doi-asserted-by":"crossref","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;1:837\u201345.","DOI":"10.2307\/2531595"},{"issue":"21","key":"4752_CR22","doi-asserted-by":"publisher","first-page":"34954","DOI":"10.18632\/oncotarget.16865","volume":"8","author":"L Xu","year":"2017","unstructured":"Xu L, Yu S, Zhuang L, Wang P, Shen Y, Lin J, Meng Z. Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients. Oncotarget. 2017;8(21):34954.","journal-title":"Oncotarget"},{"issue":"6","key":"4752_CR23","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","volume":"48","author":"N Afdhal","year":"2008","unstructured":"Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, Weksler B, Esteban R. Thrombocytopenia associated with chronic liver disease. J Hepatol. 2008;48(6):1000\u20137.","journal-title":"J Hepatol"},{"issue":"37","key":"4752_CR24","doi-asserted-by":"publisher","first-page":"e1431","DOI":"10.1097\/MD.0000000000001431","volume":"94","author":"Q Pang","year":"2015","unstructured":"Pang Q, Qu K, Zhang JY, Song SD, Liu SS, Tai MH, Liu HC, Liu C. The prognostic value of platelet count in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Medicine. 2015;94(37):e1431.","journal-title":"Medicine"},{"issue":"7","key":"4752_CR25","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/cancers16071293","volume":"16","author":"L Kraj","year":"2024","unstructured":"Kraj L, Chmiel P, Gryziak M, Grabowska-Derlatka L, Szyma\u0144ski \u0141, Wysoki\u0144ska E. Impact of thrombocytopenia on survival in patients with hepatocellular carcinoma: updated meta-analysis and systematic review. Cancers. 2024;16(7):1293.","journal-title":"Cancers"},{"issue":"4","key":"4752_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/20014091084227","volume":"38","author":"JB Whitfield","year":"2001","unstructured":"Whitfield JB. Gamma-glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38(4):263\u2013355.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"4","key":"4752_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/mutage\/6.4.241","volume":"6","author":"AA Stark","year":"1991","unstructured":"Stark AA. Oxidative metabolism of glutathione by \u03b3-glutamyl transpeptidase and peroxisome proliferation: the relevance to hepatocarcinogenesis. A hypothesis. Mutagenesis. 1991;6(4):241\u20135.","journal-title":"Mutagenesis"},{"key":"4752_CR28","doi-asserted-by":"publisher","first-page":"1291840","DOI":"10.3389\/fimmu.2024.1291840","volume":"15","author":"S Zhang","year":"2024","unstructured":"Zhang S, Tang Z. Prognostic and clinicopathological significance of systemic inflammation response index in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Front Immunol. 2024;15:1291840.","journal-title":"Front Immunol"},{"key":"4752_CR29","doi-asserted-by":"crossref","unstructured":"Li Z, Luo J, Peng L, Wu B, Yu Z. Prognostic significance of systemic immune-inflammation index in hepatocellular carcinoma: a meta-analysis. Clin Translational Oncol. 2025;19:1\u20136.","DOI":"10.1007\/s12094-025-04028-3"},{"issue":"38","key":"4752_CR30","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.3748\/wjg.v24.i38.4330","volume":"24","author":"D Omran","year":"2018","unstructured":"Omran D, Alboraie M, Zayed RA, Wifi MN, Naguib M, Eltabbakh M, Abdellah M, Sherief AF, Maklad S, Eldemellawy HH, Saad OK. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations. World J Gastroenterol. 2018;24(38):4330.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"4752_CR31","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/hep.27222","volume":"60","author":"HB El-Serag","year":"2014","unstructured":"El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology. 2014;60(5):1767\u201375.","journal-title":"Hepatology"},{"issue":"1","key":"4752_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12944-025-02710-7","volume":"24","author":"MM Elhoseeny","year":"2025","unstructured":"Elhoseeny MM, Rageh F, Bakry N, Elgamal R, Ahmed SS, Rezk SM, Othman AA. Culturally adapted hypocaloric diet improves hepatic steatosis, inflammatory and oxidative biomarkers in Egyptian MASLD patients: a single-arm interventional study. Lipids Health Dis. 2025;24(1):286.","journal-title":"Lipids Health Dis"},{"issue":"11","key":"4752_CR33","first-page":"110638","volume":"17","author":"RS Hafez","year":"2025","unstructured":"Hafez RS, Semeya AA, Elgamal R, Othman AA. Direct-acting antiviral therapy reduces variceal rebleeding and improves liver function in hepatitis C virus-related cirrhosis: A multicenter retrospective cohort study. World J Hepatol. 2025;17(11):110638.","journal-title":"World J Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04752-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04752-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04752-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:54:29Z","timestamp":1781646869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04752-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4752"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04752-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"1 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was gained according to the Scientific Research Ethics Committee of Kafr Elsheikh University, Egypt, Approval #: Reference No. KFSIRB200-817. All subjects were informed and gave their voluntary, written informed consent. It is declared that: All methods were carried out according to relevant guidelines and regulations. The study was conducted in accordance with the principles of Good Clinical Practice and the Declaration of Helsinki (2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"229"}}